Creative Biolabs-Immuno-oncology

PharmaOnco™ Y14 (SARS-CoV-2) Peptide Pool (CAT#: ITS-0622-YT221)

DatasheetDatasheet
Product Overview
The Y14 (SARS-CoV-2) Peptide Pool is a lyophilized mixture of 16 peptides from uncharacterized protein 14 (Y14) of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). The pool includes 16 peptides derived from a peptide scan (15mers with 11 aa overlap) through the entire Y14 of SARS-CoV-2 for T cell assays.
Applications
Antigen specific T-cell stimulation, Immune monitoring, T-cell assays, T-cell expansion, Cellular immune response
Size
~25 µg/peptide
Species
Human
Number of Peptides
16
Source
Severe Acute Respiratory Syndrome-related coronavirus 2 (SARS-CoV-2)
Recommended Use
The peptide pool is recommended to use for in-vitro T cell expansion, stimulation of antigen-specific T cells in T cell assays such as ELISpot, cytokine staining, cell-mediated cytotoxicity or proliferation assays.
Area of Interest
Immunology
Limitation
Restrictions for research use only. Intended for use by laboratory professionals.
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.